Literature DB >> 9402367

Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project.

K Ekdahl1, I Ahlinder, H B Hansson, E Melander, S Mölstad, M Söderström, K Persson.   

Abstract

As a part of an intervention project, all detected carriers of penicillin-resistant pneumococci (PRP) (MIC, > or = 0.5 mg/L) in Malmöhus County, southern Sweden, were followed by means of weekly nasopharyngeal cultures. The median duration of carriage in 678 individuals was 19 days (range, 3-267 days). The duration of carriage was longest in children < 1 year old (median, 30 days) and shortest in adults > 18 years old (median, 14 days). Index cases, whose cultures were performed during an acute infection, were carriers for a mean of 10 days longer than asymptomatic contact cases (P < .05). The PRP spontaneously disappeared from the nasopharynx within 4 weeks in 68%, within 8 weeks in 87%, and within 12 weeks in 94% of the individuals. Other significant risk factors for prolonged carriage were the occurrence of > 6 episodes of acute otitis media (AOM) or first episode of AOM before the age of 1 year (P < .01), the carriage of PRP by other family members (P < .05), and the obtainment of a first positive culture during the winter months (P < .05).

Entities:  

Mesh:

Year:  1997        PMID: 9402367     DOI: 10.1086/516103

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci.

Authors:  Liselotte Högberg; Patricia Geli; Håkan Ringberg; Eva Melander; Marc Lipsitch; Karl Ekdahl
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

2.  The influence of hitchhiking and deleterious mutation upon asexual mutation rates.

Authors:  Michael E Palmer; Marc Lipsitch
Journal:  Genetics       Date:  2006-02-19       Impact factor: 4.562

3.  Outbreak of Pneumococcal Pneumonia among Military Recruits.

Authors:  A Banerjee; A T Kalghatgi; G S Saiprasad; A Nagendra; B N Panda; S K Dham; A Mahen; K D Menon; M A Khan
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

5.  Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics.

Authors:  Lulla Opatowski; Jonas Mandel; Emmanuelle Varon; Pierre-Yves Boëlle; Laura Temime; Didier Guillemot
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

6.  Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization.

Authors:  Tera L McCool; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis.

Authors:  Andreas E Zautner; Merit Krause; Gerhard Stropahl; Silva Holtfreter; Hagen Frickmann; Claudia Maletzki; Bernd Kreikemeyer; Hans Wilhelm Pau; Andreas Podbielski
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

Review 8.  Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Authors:  Jack B Anon; Michael R Jacobs; Michael D Poole; Paul G Ambrose; Mark S Benninger; James A Hadley; William A Craig
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

Review 9.  Narrow versus broad spectrum antibacterials: factors in the selection of pneumococcal resistance to beta-lactams.

Authors:  Claude Carbon; Raul Isturiz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

10.  What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?

Authors:  Caroline Colijn; Ted Cohen; Christophe Fraser; William Hanage; Edward Goldstein; Noga Givon-Lavi; Ron Dagan; Marc Lipsitch
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.